NZ182329A - Cyclohexane derivatives and pharmaceutical compositions - Google Patents

Cyclohexane derivatives and pharmaceutical compositions

Info

Publication number
NZ182329A
NZ182329A NZ182329A NZ18232976A NZ182329A NZ 182329 A NZ182329 A NZ 182329A NZ 182329 A NZ182329 A NZ 182329A NZ 18232976 A NZ18232976 A NZ 18232976A NZ 182329 A NZ182329 A NZ 182329A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
cyclohexane derivatives
cyclohexane
derivatives
pharmaceutical
Prior art date
Application number
NZ182329A
Other languages
English (en)
Inventor
U Lerch
K Seegar
G Beck
W Bartmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ182329A publication Critical patent/NZ182329A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0058Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a not condensed ring different from a five-membered ring
    • C07C405/0066Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a not condensed ring different from a five-membered ring to a six-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ182329A 1975-10-16 1976-10-14 Cyclohexane derivatives and pharmaceutical compositions NZ182329A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752546313 DE2546313A1 (de) 1975-10-16 1975-10-16 Neue cyclohexanderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
NZ182329A true NZ182329A (en) 1978-06-02

Family

ID=5959272

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ182329A NZ182329A (en) 1975-10-16 1976-10-14 Cyclohexane derivatives and pharmaceutical compositions

Country Status (14)

Country Link
JP (1) JPS5268150A (de)
AU (1) AU1873976A (de)
BE (1) BE847400A (de)
DE (1) DE2546313A1 (de)
DK (1) DK465476A (de)
ES (2) ES452299A1 (de)
FR (1) FR2327768A1 (de)
IL (1) IL50678A0 (de)
IT (1) IT1069025B (de)
LU (1) LU76018A1 (de)
NL (1) NL7611347A (de)
NZ (1) NZ182329A (de)
SE (1) SE7611507L (de)
ZA (1) ZA766178B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe

Also Published As

Publication number Publication date
ES452299A1 (es) 1977-11-01
BE847400A (fr) 1977-04-18
LU76018A1 (de) 1977-05-25
FR2327768A1 (fr) 1977-05-13
ZA766178B (en) 1977-09-28
IT1069025B (it) 1985-03-21
JPS5268150A (en) 1977-06-06
AU1873976A (en) 1978-04-20
DE2546313A1 (de) 1977-04-28
IL50678A0 (en) 1976-12-31
SE7611507L (sv) 1977-04-17
ES458771A1 (es) 1978-03-16
NL7611347A (nl) 1977-04-19
DK465476A (da) 1977-04-17

Similar Documents

Publication Publication Date Title
NZ181726A (en) Pyrrolidine derivatives and pharmaceutical compositions
NZ181444A (en) -phenyl benzylidene derivatives and pharmaceutical compositions
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ182837A (en) Glucosamine derivatives and pharmaceutical compositions
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
NZ179835A (en) Aminoalkynoic acids,derivatives and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
NZ182665A (en) Amine derivatives and pharmaceutical compositions
NZ182190A (en) Clavulanic acid derivatives and pharmaceutical compositions
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
PH16022A (en) Acylamino derivatives and pharmaceutical compositions thereof
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ182555A (en) Spiro(1,3-dioxalane-4,3)-quinuclidine derivatives and pharmaceutical compositions
NZ180379A (en) Benzophenone derivatives and pharmaceutical composition
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
AU507272B2 (en) Pharmaceutical compositions and compounds
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
IL48453A0 (en) Novel quinuclidine derivatives and pharmaceutical compositions containing them
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
NZ180535A (en) Erythromicin derivatives and pharmaceutical compositions
PH13912A (en) Substituted benzamide derivatives and pharmaceutical compositions thereof